{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:21:38Z","timestamp":1741238498037,"version":"3.38.0"},"reference-count":31,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.nephro.2011.04.005","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T07:39:36Z","timestamp":1308987576000},"page":"41-46","source":"Crossref","is-referenced-by-count":4,"title":["Traitement de la carence martiale en pr\u00e9dialyse par l\u2019administration intraveineuse de doses \u00e9lev\u00e9es de fer dextran de bas poids mol\u00e9culaire"],"prefix":"10.1684","volume":"8","author":[{"given":"Patrick","family":"Fievet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Coppin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Demontis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2011.04.005_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2215\/CJN.01670408","article-title":"Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004","volume":"4","author":"Fishbane","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2011.04.005_bib0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1681\/ASN.V132504","article-title":"Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the third National Health and Nutrition Examination Survey","volume":"13","author":"Hsu","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2011.04.005_bib0015","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ndt\/gfl716","article-title":"Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients","volume":"22","author":"Rossert","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2011.04.005_bib0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin \u03b1 dose and achieved haemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2011.04.005_bib0025","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1056\/NEJMoa1005109","article-title":"Erythropoietic response and outcomes in kidney disease and type\u00a02 diabetes","volume":"363","author":"Salomon","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2011.04.005_bib0030","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2008.05.033","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis","volume":"52","author":"Rozen-Zvi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2011.04.005_bib0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/ajkd.1998.v31.pm9428456","article-title":"A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients","volume":"31","author":"Auerbach","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2011.04.005_bib0040","first-page":"301","article-title":"Eisen-sextran intravenous: therapeutische und experimentelle M\u00f4glichkeiten","volume":"100","author":"Ganzoni","year":"1970","journal-title":"Schweiz Med Wschr"},{"key":"10.1016\/j.nephro.2011.04.005_bib0045","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1055\/s-0028-1107912","article-title":"Orale einsenmedikation Vertraglichkert von eisensulfat und eisensulfat+bernsteinsaure. Einfluss auf die hamoglobinkonzentration gesunder","volume":"99","author":"Ganzoni","year":"1974","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1016\/j.nephro.2011.04.005_bib0050","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/ajkd.2001.28587","article-title":"Intravenous iron sucrose: establishing a safe dose","volume":"38","author":"Chandler","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2011.04.005_bib0055","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1038\/sj.ki.5001973","article-title":"Recent experience with highdose intravenous iron administration","volume":"70","author":"Blaustein","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2011.04.005_bib0060","first-page":"S337","article-title":"Treatment of the martial deficiencies: preparations available in France","volume":"2","author":"Ranfaing","year":"2006","journal-title":"N\u00e9phrologie & Th\u00e9rapeutique"},{"key":"10.1016\/j.nephro.2011.04.005_bib0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0272-6386(96)90546-6","article-title":"Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis","volume":"27","author":"Silverberg","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2011.04.005_bib0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1081\/JDI-100100849","article-title":"Total dose iron infusion: safety and efficacy in predialysis patients","volume":"22","author":"Bhowmik","year":"2000","journal-title":"Ren Fail"},{"key":"10.1016\/j.nephro.2011.04.005_bib0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1081\/JDI-120005364","article-title":"Total dose infusion iron dextran therapy in predialysis chronic renal failure","volume":"24","author":"Anuradha","year":"2002","journal-title":"Ren Fail"},{"key":"10.1016\/j.nephro.2011.04.005_bib0080","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/j.1523-1755.2005.00758.x","article-title":"A randomized, controlled trial comparing intravenous iron sucrose to oral iron in anemic patients with non dialysis-dependent CKD","volume":"68","author":"Van Wyck","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2011.04.005_bib0085","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000096174","article-title":"A randomized controlled trial of oral versus intravenous iron in chronic kidney disease","volume":"26","author":"Agarwal","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2011.04.005_bib0090","first-page":"161","article-title":"Iron deficiency is a common cause of anemia in chronic kidney disease and can be corrected with intravenous iron","volume":"19","author":"Gotloib","year":"2006","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2011.04.005_bib0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ndt\/gfi087","article-title":"Intravenous supplementation for the treatment of anaemia in predialyzed chronic renal failure patients","volume":"21","author":"Mircescu","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2011.04.005_bib0100","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1681\/ASN.2007101156","article-title":"Ferumoxytol for treating iron deficiency anemia in CKD","volume":"19","author":"Spinowitz","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2011.04.005_bib0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1755-6686.2008.00026.x","article-title":"Intravenous iron in chronic kidney disease; haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin","volume":"34","author":"Tagboto","year":"2008","journal-title":"J Renal Care"},{"key":"10.1016\/j.nephro.2011.04.005_bib0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1755-6686.2009.00075.x","article-title":"The efficacy of a single dose of intravenous ferric carboxymaltose (Ferinject\u00ae) on anaemia in a predialysis population of chronic kidney disease patients","volume":"35","author":"Tagboto","year":"2009","journal-title":"J Renal Care"},{"key":"10.1016\/j.nephro.2011.04.005_bib0115","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Qunibi","year":"2011","journal-title":"Nephrol Dial Tranplant"},{"key":"10.1016\/j.nephro.2011.04.005_bib0120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron","volume":"21","author":"Chertow","year":"2006","journal-title":"Nephrol Dial Tranplant"},{"key":"10.1016\/j.nephro.2011.04.005_bib0125","doi-asserted-by":"crossref","unstructured":"K\/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 2006;47:S11\u2013145.","DOI":"10.1053\/j.ajkd.2006.03.011"},{"key":"10.1016\/j.nephro.2011.04.005_bib0130","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to EPO therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"issue":"1790","key":"10.1016\/j.nephro.2011.04.005_bib0135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbagen.2008.10.010","article-title":"Iron transport and the kidney","volume":"18","author":"Smith","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nephro.2011.04.005_bib0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1469-7793.2000.00581.x","article-title":"In vivo characterization of renal iron transport in the anaesthetized rat","volume":"524","author":"Wareing","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.nephro.2011.04.005_bib0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1582-4934.2009.00985.x","article-title":"Ferroportin\u00a01\u00a0is expressed basolaterally in rat kidney proximal tubule cells and iron excess increases its membrane trafficking","volume":"15","author":"Wolff","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nephro.2011.04.005_bib0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1523-1755.2004.00716.x","article-title":"Parenteral iron nephrotoxicity: potential mechanisms and consequence","volume":"66","author":"Zager","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2011.04.005_bib0155","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.ki.5002422","article-title":"Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease","volume":"72","author":"Agarwall","year":"2007","journal-title":"Kidney Int"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725511000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725511000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2011.04.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:05:24Z","timestamp":1741187124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725511000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1769725511000873"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2011.04.005","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}